Assessment of Sleep Quality in Patients Treated for Cancer Between 15 and 24 Years of Age

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age15-24
SponsorCentre Hospitalier Universitaire de Nice

About this trial

Medical professionals now take into account the specificities of the care and support of Adolescents and Young Adults (AYAs). Cancer aftermaths in patients diagnosed during the AYA period are also known: the consequences of chemotherapy and radiotherapy treatments on a growing organism, the difficulty of some follow-ups, the longevity, and the delayed occurrence of certain complications.

In the general population, sleep disorders affect 40% of adolescents. About 30% of pediatric cancer survivors experience fatigue they attribute to their cancer, even years after the end of their treatment. The sleep quality of patients treated for cancer when they were AYAs, and the eventual care of sleeping disorders, are poorly studied. The investigators suppose that the oncologic treatment during this particular life stage, when sleeping disorders are already present and multifactorial, could have long-term impacts on sleep. The investigators offer to evaluate, through a questionnaire filled out by patients treated for cancer in the AYA period, the frequency of moderate to severe insomnia.

Eligibility criteria

Qualifiers

Patient treated for a cancer

Patient aged between 15 and 24 years old at the time of the diagnosis

Patients whom intensive treatment ended at least 3 months ago

Patient followed in a PACAAURA cancerology center

Disqualifiers

Patient unable to use informatic tools

Known superior cognitive function disorders

Progressive psychiatric pathology

Drug user or alcohol abuse

Trial design

Treatments tested in this trial

  • Survey of sleep quality and associated factors

Treatment groups

400 Participants
are divided into 1 treatment group